FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
4589PDF: 4004Supplementary: 465Appendix: 399 -
2026 iCARDIO Alliance Global Implementation Guidelines on Ischemic Heart Disease
1295PDF: 659APPENDIX: 72HTML: 3 -
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
4933PDF: 834Appendix: 538HTML: 59 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
1165PDF: 453Supplementary: 259Appendix: 196HTML: 147 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1567pdf: 422Supplementary Material: 103HTML: 245 -
Obesity and left atrial function: state of the art
1059PDF: 379HTML: 156 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
1044PDF: 397Supplementary: 227Appendix: 245HTML: 74 -
What is new and what has changed in the 2026 Global Heart Failure Implementation Guidelines and why
571PDF: 435APPENDIX: 41HTML: 3 -
Applicability of obesity clinical practice guidelines in low- and middle-income countries
1829PDF: 910Appendix: 326HTML: 59 -
The impact of frailty on in-hospital outcomes in patients with HFrEF
725PDF: 326Supplementary: 124HTML: 31 -
2026 iCARDIO Alliance Global Implementation Guidelines on Heart Failure
1867PDF: 1035APPENDIX: 66HTML: 3 -
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025
16229PDF: 9482Appendix: 1209
1 - 23 of 23 items

